TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions
Brain · 2024
DOI: 10.1093/brain/awad301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Hashem Almousa und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Concordia University, Montreal, Quebec H4B1R6, Canada. Hauptthemen laut MEDLINE: Microcephaly, Intellectual Disability, Dystonia, Neurodevelopmental Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, Cerebral Palsy Alliance Research Foundation.
Abstract (Originalsprache)
Highly conserved transport protein particle (TRAPP) complexes regulate subcellular trafficking pathways. Accurate protein trafficking has been increasingly recognized to be critically important for normal development, particularly in the nervous system. Variants in most TRAPP complex subunits have been found to lead to neurodevelopmental disorders with diverse but overlapping phenotypes. We expand on limited prior reports on TRAPPC6B with detailed clinical and neuroradiologic assessments, and studies on mechanisms of disease, and new types of variants. We describe 29 additional patients from 18 independent families with biallelic variants in TRAPPC6B. We identified seven homozygous nonsense (n = 12 patients) and eight canonical splice-site variants (n = 17 patients). In addition, we identified one patient with compound heterozygous splice-site/missense variants with a milder phenotype and one patient with homozygous missense variants. Patients displayed non-progressive microcephaly, global developmental delay/intellectual disability, epilepsy and absent expressive language. Movement disorders including stereotypies, spasticity and dystonia were also observed. Brain imaging revealed reductions in cortex, cerebellum and corpus callosum size with frequent white matter hyperintensity. Volumetric measurements indicated globally diminished volume rather than specific regional losses. We identified a reduced rate of trafficking into the Golgi apparatus and Golgi fragmentation in patient-derived fibroblasts that was rescued by wild-type TRAPPC6B. Molecular studies revealed a weakened interaction between mutant TRAPPC6B (c.454C>T, p.Q152*) and its TRAPP binding partner TRAPPC3. Patient-derived fibroblasts from the TRAPPC6B (c.454C>T, p.Q152*) variant displayed reduced levels of TRAPPC6B as well as other TRAPP II complex-specific members (TRAPPC9 and TRAPPC10). Interestingly, the levels of the TRAPPC6B homologue TRAPPC6A were found to be elevated. Moreover, co-immunoprecipitation experiments showed that TRAPPC6A co-precipitates equally with TRAPP II and TRAPP III, while TRAPPC6B co-precipitates significantly more with TRAPP II, suggesting enrichment of the protein in the TRAPP II complex. This implies that variants in TRAPPC6B may preferentially affect TRAPP II functions compared to TRAPP III functions. Finally, we assessed phenotypes in a Drosophila TRAPPC6B-deficiency model. Neuronal TRAPPC6B knockdown impaired locomotion and led to wing posture defects, supporting a role for TRAPPC6B in neuromotor function. Our findings confirm the association of damaging biallelic TRAPPC6B variants with microcephaly, intellectual disability, language impairments, and epilepsy. A subset of patients also exhibited dystonia and/or spasticity with impaired ambulation. These features overlap with disorders arising from pathogenic variants in other TRAPP subunits, particularly components of the TRAPP II complex. These findings suggest that TRAPPC6B is essential for brain development and function, and TRAPP II complex activity may be particularly relevant for mediating this function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Concordia University, Montreal, Quebec H4B1R6, Canada.
- Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
- Departments of Child Health, Cellular and Molecular Medicine, Genetics, and Neurology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
- CSIRO Health and Biosecurity, The Australian e-Health Research Centre, Brisbane 4029, Australia.
- Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
- Pediatric Neuroradiology Division, Pediatric Radiology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
ORCID-Profile: Stephanie Efthymiou, Sheng Chih Jin, Mina Zamani, Saeid Sadeghian, Fowzan Alkuraya, Henry Houlden, Reza Maroofian, Michael Sacher
Förderung
- NINDS NIH HHS
- NIH HHS
- Cerebral Palsy Alliance Research Foundation
- National Institutes of Health
Zitieren
APA
Almousa, H., Lewis, S. A., Bakhtiari, S., Nordlie, S. H., Pagnozzi, A., Magee, H., Efthymiou, S., Heim, J. A., Cornejo, P., Zaki, M. S., Anwar, N., Maqbool, S., Rahman, F., Neilson, D. E., Vemuri, A., Jin, S. C., Yang, X. R., Heidari, A., van Gassen, K., …, & Kruer, M. C. (2024). TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions. Brain. https://doi.org/10.1093/brain/awad301
Vancouver
Almousa H, Lewis SA, Bakhtiari S, Nordlie SH, Pagnozzi A, Magee H, et al. TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions. Brain. 2024. doi:10.1093/brain/awad301
BibTeX
@article{Almousa2024,
author = {Almousa, Hashem and Lewis, Sara A and Bakhtiari, Somayeh and Nordlie, Sandra Hinz and Pagnozzi, Alex and Magee, Helen and Efthymiou, Stephanie and Heim, Jennifer A and Cornejo, Patricia and Zaki, Maha S and Anwar, Najwa and Maqbool, Shazia and Rahman, Fatima and Neilson, Derek E and Vemuri, Anusha and Jin, Sheng Chih and Yang, Xiao-Ru and Heidari, Abolfazl and van Gassen, Koen and Trimouille, Aurélien and Thauvin-Robinet, Christel and Liu, James and Bruel, Ange-Line and Tomoum, Hoda and Shata, Mennatallah O and Hashem, Mais O and Toosi, Mehran Beiraghi and Karimiani, Ehsan Ghayoor and Yeşil, Gözde and Lingappa, Lokesh and Baruah, Debangana and Ebrahimzadeh, Farnoosh and Van-Gils, Julien and Faivre, Laurence and Zamani, Mina and Galehdari, Hamid and Sadeghian, Saeid and Shariati, Gholamreza and Mohammad, Rahema and van der Smagt, Jasper and Qari, Alya and Vincent, John B and Innes, A Micheil and Dursun, Ali and Özgül, R Köksal and Akar, Halil Tuna and Bilguvar, Kaya and Mignot, Cyril and Keren, Boris and Raveli, Claudia and Burglen, Lydie and Afenjar, Alexandra and Kaat, Laura Donker and van Slegtenhorst, Marjon and Alkuraya, Fowzan and Houlden, Henry and Padilla-Lopez, Sergio and Maroofian, Reza and Sacher, Michael and Kruer, Michael C},
title = {TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awad301}
}
EUVIMED